In 2017, everyday, more than 130 people died in the US after overdosing on opioids. This document talks about America's worst drug crisis ever and shares how technology can play a role to cope up with this epidemic.
Declaration: The materials incorporated in this document have come from variety of sources and compiler bears no responsibilities for any information contained herein. The compiler acknowledges all the sources although references have not been explicitly cited for all the contents in this document.
Declaration: The materials incorporated in this document have come from variety of sources and compiler bears no responsibilities for any information contained herein. The compiler acknowledges all the sources although references have not been explicitly cited for all the contents in this document.
Definition and scope of Pharmacoepidemiology ABUBAKRANSARI2
In these slides I shared the information of definition and scope of pharmacoepidemiology. Types of studies - cohort studies, cross-sectional studies etc.
A concise overview of pharmacoeconomics, health economics, various costs, various pharmacoeconomic study designs and its application in the field of medicine and drug development
This lecture slides are prepared for Refresher course for pharmacist. Essential Medicines, Rational use of drugs and Self medication, These are the topics covered in this ppt.These slides are also useful for other medical undergraduates and post graduates students.
Definition and scope of Pharmacoepidemiology ABUBAKRANSARI2
In these slides I shared the information of definition and scope of pharmacoepidemiology. Types of studies - cohort studies, cross-sectional studies etc.
A concise overview of pharmacoeconomics, health economics, various costs, various pharmacoeconomic study designs and its application in the field of medicine and drug development
This lecture slides are prepared for Refresher course for pharmacist. Essential Medicines, Rational use of drugs and Self medication, These are the topics covered in this ppt.These slides are also useful for other medical undergraduates and post graduates students.
Integration of health records in the prescription drug monitoring programAlayziaHarris
Through the Future of Florida Summit hosted by UF's Bob Graham Center, my team and I were tasked to find solutions to a current health issue. We wanted to focus on the opioid epidemic and tackle this crisis by implementing improvements towards regulation.
ER visits for opioid overdoses is rising in the U.S. Accurate ER reports from medical transcription services and proactive action can help minimize risks.
its not my personal work presentation but taken from lecture ppt from university of San Diego, california.
Its about the drug discovery process, its development and its commercialization.
A new study adds further evidence to suggest that opioid prescribing in the U.S. is skewed and concentrated among a few providers. Researchers looked at prescribing patterns in data from an unspecified national private insurer between 2003-2017.
Around 670,000 providers prescribed more than 8 million standard doses of opioid prescriptions — but more than a quarter of these prescriptions were written by only 1% of physicians. And in 2017, these physicians prescribed nearly half of all the dispensed opioids. This small group of doctors also prescribed higher doses than recommended, and for longer durations than guidelines allow.
What’s encouraging, the authors suggest, is that the vast majority of physicians do seem to follow guidelines. Some caveats: The study was based on one company’s data, and didn’t look at medical reasons behind prescriptions.
Global pharmaceutical companies are modeled with a supply chain, which ensures that the right drug reaches the right people at the right time and in the right condition. The supply chain also ensures 100% product availability at optimum cost by carrying huge inventory, which maintains 100% fill rate. Manufacturers are trying to cut down development time to save costs. For example, a drug manufacturer who can trim development time by 19% can save up to USD 100 million. But if a drug is getting delayed to reach the market, the time delay costs the company around USD 1 million a day. So, pharmaceutical companies today are designing the supply chain to be as responsive as possible to reduce entry time to the market thereby increasing profit margins.
Please share this video with anyone who may be interested!
Watch all our webinars: https://www.youtube.com/playlist?list=PL4dDQscmFYu_ezxuxnAE61hx4JlqAKXpR
In this webinar:
● Takeaways from a roundtable held on June 1st about patient-centred pharmacare in Canada
● Reports from patient groups and other subject matter experts
● A cohesive vision and set of values for national pharmacare in Canada
View the video: https://youtu.be/HMy_gsTDkfI
Follow our social media accounts:
Twitter - https://twitter.com/survivornetca
Facebook - https://www.facebook.com/CanadianSurvivorNet
Pinterest - https://www.pinterest.com/survivornetwork
YouTube - https://www.youtube.com/user/Survivornetca
April 3, 2017
The current opiate epidemic has spurred long-overdue scrutiny on the pharmaceutical production and distribution of opiate medication, but it also raises questions of public policy and law regarding the regulation of medical access to and use of opiate medications with high potential for addiction. Expert panelists will address the challenges that arise from efforts to balance restrictions on access to opiates to limit addiction while also preserving sufficient access for legitimate medical management of pain.
Learn more on our website: http://petrieflom.law.harvard.edu/events/details/opiate-regulation-policies
Patient-centered pharmacovigilance represents a pivotal shift in the landscape of healthcare, emphasizing the active involvement of patients in the monitoring and reporting of adverse drug reactions. Unlike traditional pharmacovigilance, which primarily relies on healthcare professionals to identify and document adverse events, this approach recognizes patients as critical stakeholders in ensuring medication safety. By empowering patients to share their experiences, concerns, and observations regarding medication effects, whether positive or negative, healthcare systems can gain a comprehensive understanding of drug safety and efficacy in real-world settings. Patient-centered pharmacovigilance fosters a collaborative partnership between patients, healthcare providers, and regulatory agencies, promoting transparency, accountability, and ultimately, better patient outcomes. Through increased patient engagement and the utilization of patient-reported data, this approach enables healthcare systems to identify potential safety issues earlier, tailor treatment strategies to individual needs, and enhance overall drug safety surveillance efforts.
A project to increase access to HIV treatment in middle income countries. The project funded by UNITAID is led by International Treatment Preparedness Coaliton (ITPC). The presentation is prepared by Solange Baptiste from ITPC.
The presentation explains why the project focuses on middle-income countries, explains the intervention, describing objectives and outcomes.
Member Engagement Using Sentiment Analysis for Health PlansCitiusTech
Sentiment analysis (or opinion mining) is a natural language processing technique used to determine whether data is positive, negative or neutral. Sentiment analysis for health plans deals with member opinions to improve healthcare services and patient experience.
Evolving Role of Digital Biomarkers in HealthcareCitiusTech
As the adoption of remote monitoring, wearable devices and mobile applications grows, digital biomarkers will play a significant role in better disease identification and health management.
Virtual Care: Key Challenges & Opportunities for Payer Organizations CitiusTech
The pandemic has increased interest in the use of telehealth services by providers and patients. Payers are steadily recognizing the need for "virtual-first" health plans to provide consumers with quick access while ensuring significant cost savings.
The convergence of health plans and healthcare providers has led to the growing importance for provider-led health plans (Payviders). This eBook highlights the data and technology capabilities necessary for Payvider organizations to optimize performance and drive operational efficiencies.
CMS Medicare Advantage 2021 Star Ratings: An AnalysisCitiusTech
This report is intended for business, consulting, and technology audience who are actively engaged, or impacted, with the functioning of Medicare Advantage Star ratings, to help them align their star improvement initiatives to the market trends.
Accelerate Healthcare Technology Modernization with Containerization and DevOpsCitiusTech
As healthcare industry evolves, organizations and technology companies need to address issues around quality, consistency, and speed to market initiatives. DevOps with containerization gives them a strategic advantage as they build and accelerate modernization.
Leveraging Analytics to Identify High Risk PatientsCitiusTech
A predictive analytics platform can help healthcare providers identify which patients and team members could be at the highest risk for severe illness / hospitalization.
Health plans must systematically engage with providers to ensure better cost, care, quality, and revenue outcomes. Improved provider engagement enables interactive closure of care gaps and allows providers to proactively improve payer quality scores.
Demystifying Robotic Process Automation (RPA) & Automation TestingCitiusTech
Although RPA and automation testing are two different aspects of automation, both have certain similarities too. Here’s our perspective to debunk all myths and highlights facts around RPA and automation testing.
RPA (Robotic Process Automation) promises to automate various complex tasks for healthcare organizations – payers and providers – to improve member experience, lower costs and relieve employees from rising pressure of work. But when it comes to actual applications of RPA, most companies are having a difficult time. This brief eBook outlines the benefits, challenges, tools and key healthcare use cases of RPA that can help healthcare organizations boost their productivity.
NLP (Natural Language Processing) shows a great deal of potential for many applications in the healthcare industry. This document shares 6 promising use cases for NLP to manage Epilepsy treatment effectively.
Rising Importance of Health Economics & Outcomes ResearchCitiusTech
Health Economics & Outcomes Research (HE&OR) guides stakeholders to make informed decisions regarding patient access to drugs and services. This document highlights specific use cases for healthcare information technology that add value to HE&OR.
The World Health Organization (WHO) released the new International Classification of Disease (ICD-11) which would come into effect in January 2022. This document takes a closer look at revisions made to the document and its possible impact on healthcare payers.
Driving Home Health Efficiency through Data AnalyticsCitiusTech
This whitepaper highlights how data analytics can help track key performance indicators to drive clinical, financial and operational efficiency to improve quality of home health in an efficient manner.
Poster Presentation - FDA Compliance Landscape & What it Means to Your AI Asp...CitiusTech
CitiusTech delivered a poster presentation on the FDA compliance landscape (PMA, De Novo, 510k and Pre Cert) and its implication on AI in Healthcare, at the Mayo Clinic AI Symposium earlier this year.
Accelerate your Kubernetes clusters with Varnish CachingThijs Feryn
A presentation about the usage and availability of Varnish on Kubernetes. This talk explores the capabilities of Varnish caching and shows how to use the Varnish Helm chart to deploy it to Kubernetes.
This presentation was delivered at K8SUG Singapore. See https://feryn.eu/presentations/accelerate-your-kubernetes-clusters-with-varnish-caching-k8sug-singapore-28-2024 for more details.
Slack (or Teams) Automation for Bonterra Impact Management (fka Social Soluti...Jeffrey Haguewood
Sidekick Solutions uses Bonterra Impact Management (fka Social Solutions Apricot) and automation solutions to integrate data for business workflows.
We believe integration and automation are essential to user experience and the promise of efficient work through technology. Automation is the critical ingredient to realizing that full vision. We develop integration products and services for Bonterra Case Management software to support the deployment of automations for a variety of use cases.
This video focuses on the notifications, alerts, and approval requests using Slack for Bonterra Impact Management. The solutions covered in this webinar can also be deployed for Microsoft Teams.
Interested in deploying notification automations for Bonterra Impact Management? Contact us at sales@sidekicksolutionsllc.com to discuss next steps.
DevOps and Testing slides at DASA ConnectKari Kakkonen
My and Rik Marselis slides at 30.5.2024 DASA Connect conference. We discuss about what is testing, then what is agile testing and finally what is Testing in DevOps. Finally we had lovely workshop with the participants trying to find out different ways to think about quality and testing in different parts of the DevOps infinity loop.
Essentials of Automations: Optimizing FME Workflows with ParametersSafe Software
Are you looking to streamline your workflows and boost your projects’ efficiency? Do you find yourself searching for ways to add flexibility and control over your FME workflows? If so, you’re in the right place.
Join us for an insightful dive into the world of FME parameters, a critical element in optimizing workflow efficiency. This webinar marks the beginning of our three-part “Essentials of Automation” series. This first webinar is designed to equip you with the knowledge and skills to utilize parameters effectively: enhancing the flexibility, maintainability, and user control of your FME projects.
Here’s what you’ll gain:
- Essentials of FME Parameters: Understand the pivotal role of parameters, including Reader/Writer, Transformer, User, and FME Flow categories. Discover how they are the key to unlocking automation and optimization within your workflows.
- Practical Applications in FME Form: Delve into key user parameter types including choice, connections, and file URLs. Allow users to control how a workflow runs, making your workflows more reusable. Learn to import values and deliver the best user experience for your workflows while enhancing accuracy.
- Optimization Strategies in FME Flow: Explore the creation and strategic deployment of parameters in FME Flow, including the use of deployment and geometry parameters, to maximize workflow efficiency.
- Pro Tips for Success: Gain insights on parameterizing connections and leveraging new features like Conditional Visibility for clarity and simplicity.
We’ll wrap up with a glimpse into future webinars, followed by a Q&A session to address your specific questions surrounding this topic.
Don’t miss this opportunity to elevate your FME expertise and drive your projects to new heights of efficiency.
The Art of the Pitch: WordPress Relationships and SalesLaura Byrne
Clients don’t know what they don’t know. What web solutions are right for them? How does WordPress come into the picture? How do you make sure you understand scope and timeline? What do you do if sometime changes?
All these questions and more will be explored as we talk about matching clients’ needs with what your agency offers without pulling teeth or pulling your hair out. Practical tips, and strategies for successful relationship building that leads to closing the deal.
Epistemic Interaction - tuning interfaces to provide information for AI supportAlan Dix
Paper presented at SYNERGY workshop at AVI 2024, Genoa, Italy. 3rd June 2024
https://alandix.com/academic/papers/synergy2024-epistemic/
As machine learning integrates deeper into human-computer interactions, the concept of epistemic interaction emerges, aiming to refine these interactions to enhance system adaptability. This approach encourages minor, intentional adjustments in user behaviour to enrich the data available for system learning. This paper introduces epistemic interaction within the context of human-system communication, illustrating how deliberate interaction design can improve system understanding and adaptation. Through concrete examples, we demonstrate the potential of epistemic interaction to significantly advance human-computer interaction by leveraging intuitive human communication strategies to inform system design and functionality, offering a novel pathway for enriching user-system engagements.
Generating a custom Ruby SDK for your web service or Rails API using Smithyg2nightmarescribd
Have you ever wanted a Ruby client API to communicate with your web service? Smithy is a protocol-agnostic language for defining services and SDKs. Smithy Ruby is an implementation of Smithy that generates a Ruby SDK using a Smithy model. In this talk, we will explore Smithy and Smithy Ruby to learn how to generate custom feature-rich SDKs that can communicate with any web service, such as a Rails JSON API.
GraphRAG is All You need? LLM & Knowledge GraphGuy Korland
Guy Korland, CEO and Co-founder of FalkorDB, will review two articles on the integration of language models with knowledge graphs.
1. Unifying Large Language Models and Knowledge Graphs: A Roadmap.
https://arxiv.org/abs/2306.08302
2. Microsoft Research's GraphRAG paper and a review paper on various uses of knowledge graphs:
https://www.microsoft.com/en-us/research/blog/graphrag-unlocking-llm-discovery-on-narrative-private-data/
Transcript: Selling digital books in 2024: Insights from industry leaders - T...BookNet Canada
The publishing industry has been selling digital audiobooks and ebooks for over a decade and has found its groove. What’s changed? What has stayed the same? Where do we go from here? Join a group of leading sales peers from across the industry for a conversation about the lessons learned since the popularization of digital books, best practices, digital book supply chain management, and more.
Link to video recording: https://bnctechforum.ca/sessions/selling-digital-books-in-2024-insights-from-industry-leaders/
Presented by BookNet Canada on May 28, 2024, with support from the Department of Canadian Heritage.
Leading Change strategies and insights for effective change management pdf 1.pdf
Opioid Epidemic - Causes, Impact and Future
1. This document is confidential and contains proprietary information, including trade secrets of CitiusTech. Neither the document nor any of the information
contained in it may be reproduced or disclosed to any unauthorized person under any circumstances without the express written permission of CitiusTech.
Opioid Epidemic: Causes, Impact &
Future
January 2020| Author: Shiven Kalelkar; Sr. Healthcare Consultant
CitiusTech Thought
Leadership
2. 2
Agenda
▪ Opioid Epidemic: Key Trends
▪ Opioid Epidemic: Measures for Controlling the Epidemic
▪ Opioid Epidemic: What Lies in the Future
▪ References
3. 3
Opioid Epidemic: America’s Worst Drug Crisis Ever (1/2)
2011 2012 2015 2016 2017 2018
An estimated 10.3 million Americans aged
12 and older misused opioids, including 9.9
million prescription pain reliever abusers and
808,000 heroin users
>70,200 overdose deaths in
the United States and 47,600
of those overdose deaths
involved opioids
19% of US population
received one or more
opioid prescriptions
Prescription opioid volumes peaked,
with the equivalent of 240 billion
milligrams of morphine prescribed,
according to the market research firm,
IQVIA Institute for Human Data
Science
>52,000 people died of drug
overdoses, nearly two-thirds of
which were linked to opioids
like Percocet, OxyContin,
heroin, and fentanyl
US physicians wrote 259 million
prescriptions for opioid painkillers —
enough to give a bottle of pills to every
adult in the country
4. 4
Opioid Epidemic: America’s Worst Drug Crisis Ever (2/2)
▪ Drug overdoses now kill more people than gun homicides and
car crashes combined
▪ 57.8 – Highest deaths per 100,000 individuals in the state of
West Virginia
▪ Between 2007 and 2016, the most widely prescribed opioid
was hydrocodone (Vicodin)
▪ In 2016, 6.2 billion hydrocodone pills were distributed
nationwide
5. 5
Opioid Epidemic: Key Driving Factors
Creation of “Pill-Mills”
▪ Massive marketing by drug manufacturers about effectiveness & safety of opioid drugs
▪ Uncontrolled prescriptions by physicians to improve patient satisfaction & profit margins
Growth in Instances of Chronic Pain
▪ Continuous growth in patients with chronic pain – about 50mn suffer from chronic pain, with
20mn having high-impact chronic pain
▪ Opioids are the easiest, economical and readily available means to reduce the pain
▪ Alternate therapies are expensive & mostly not covered under benefit plan
Easy Access to Opioids
▪ For many years, there was neither legislation nor any kind of monitoring on consumption of
prescription drugs
▪ Easy availability of illicit drugs such as Heroin acts as substitute for opioids
Socio-economic Causes
▪ The rate of opioid mortality is found to be higher in areas with higher poverty, unemployment,
disability, single parent families, and divorce/separation
▪ Major section of population under the abuse of legally available opioids are found to be middle-
aged women (over 40 years)
6. 6
Opioid Epidemic: Multi-Dimensional Impact
Growing mortality rate
▪ Leading cause of death – Deaths due to opioids are 1.5 times the deaths caused due to road
accidents
Economic Burden
▪ Opioid Epidemics’ estimated cost to the nation in 2017: $78 Bn
Loss in Productivity
▪ Highest rate of opioid overdoses in population in age range 25 – 54 years
Burden on high cost settings
▪ The rate of ER visits for opioid overdose cases has grown to 45% in 45 states in 2017
Pre-natal effects
▪ Around 75 – 90% of the prenatal opioid–exposed infants are diagnosed with Neonatal Abstinence
Syndrome
Family crises
▪ A large section of victims are middle-aged females leading to massive disruptions in family lives
7. 7
Opioid Epidemic: Measures to Fight the Epidemic (1/2)
Litigations against drug
manufacturers &
distributors
▪ Multiple lawsuits across states against Pharma companies for fueling the crisis by
misleading data and unethical marketing practices
▪ Key defendants include Pharma giants such as J&J, Purdue Pharma, Amerisource
Bergen, McKesson Corp, Cardinal Health, etc.
▪ Purdue pharma has 2,000+ opioid lawsuits totaling to around $12 billion in
compensation
New regulations for
managing OUD (Opioid Use
Disorder)
▪ A Prescription Drug Monitoring Program (PDMP) is a statewide electronic
database to track all controlled substance prescriptions
• Data available to authorized users – medical professionals, regulatory
bodies, public health agencies, etc.
• 49 states currently participate in this program
▪ Medication Assisted Treatment (MAT) is a statewide program for rehabilitation
of OUD patients
• A combination of antidotes such as Methadone, Buprenorphine &
Naltrexone along with focus on behavioral health
• Only 22 states have currently implemented this program
▪ Modification in MIPS program – removal of Pain Management Questions from
HCAHPS survey
8. 8
Opioid Epidemic: Measures to Fight the Epidemic (2/2)
Preventive Care
▪ Increase proportion of providers using evidence-based guidelines while prescribing
opioids
▪ Develop additional tools for patients as well as care givers for using opioids
appropriately
▪ Provide timely and accurate notifications to curb overuse of opioids
▪ Modify the benefit plans to have prior authorizations/referrals for opioids
▪ Population Health Management programs to manage high risk patients
Research &
Educational Programs
▪ HHS has a 5-point strategy to fight opioid crisis which includes:
• Better research
• Improved pain management
• Availability of overdose reversing drugs
• Timely reporting of overdose data
• Better services for prevention and recovery
▪ CDC created a Strategic Framework for the opioid crisis which includes:
• Campaigns to create awareness for negative impact of opioids
• Building public health advisories to empower local communities in the fight
against opioids
• Evidence-based community level intervention programs
• Surveillance programs to improve prevention
9. 9
Opioid Epidemic: What Lies in the Future
Immediate Impact
▪ Latest reports from CMS
indicate no decline of the
opioid epidemic despite
the efforts
▪ Industry observers agree
that the rates of addiction,
overdose, and death is
likely to get worse in the
coming years before they
start improving
Ecosystem Approach
▪ An ecosystem approach
could become the best
hope in the battle against
opioid addiction
▪ Regulatory bodies and
state governments will
need to work with
providers, payers, local
agencies, law enforcement
bodies, community groups,
and individual citizens for
an optimum solution
Evidence-based Measures
▪ Stakeholders need to
develop & implement
mitigation plans that are
data driven in nature &
and responsive to
emerging trends in the
epidemic as well as best
practices
▪ Few health plans,
providers, and pharmacy
benefit managers are
taking a data driven,
evidence-based approach
to help change patient and
physician behavior
▪ There is a need for a
cutting age technology to
support these to ensure
the success of such
endeavors
10. 10
Opioid Epidemic: A Step by CMS in the Right Direction
Prevention
Significant progress has been
made in identifying
inappropriate prescribing
pattern
Treatment
Medicare, Medicaid, and
private health plans provide
some coverage for pain and
opioid use disorder treatment
Care
Data provides insights into
doctor, pharmacy, and patient
use of prescription opioids and
effectiveness of treatment
1. Identify and stop
inappropriate prescribing of
opioids
2. Enhance diagnosis of OUD to
get people the support they
need earlier
3. Promote effective, non-
opioid pain treatments
1. Ensure access to treatment
across CMS programs and
geography
2. Give patients options for
broader range of treatments
3. Support innovation through
new models and best
practices
1. Understand opioid use
patterns across populations
2. Promote sharing of
actionable data across the
continuum of care
3. Monitor trends to assess
impact of prevention and
treatment efforts
CMS can build on these efforts to further:
CMS has published a roadmap outlining its efforts to address this issue of national concern
11. 11
Key Considerations
1. Control Cost
2. Maintain High Quality of Care
3. Access to Patient Data
4. Continuous Engagement
5. Timely Interventions
Key Enablers
1. Virtual Care
2. Remote Patient Monitoring
3. Advanced Analytics
4. AI / ML
5. Natural Language Processing (NLP)
6. Digital Therapeutics
7. Internet of Things (IoT)
Opioid Epidemic: Role of Technology
Healthcare facilities need to leverage technology and tools to address prescription opioid misuse and
abuse.
12. 12
Opioid Epidemic: Potential Areas for Technology Vendors
Opioid Registries
Create a longitudinal view of OUD patient by integrating data across
multiple sources & formats – clinical, claims, SCM, social history, etc.
Regulatory Compliance
Leverage BI / Analytics and Reporting services for assisting providers with
regulatory needs – MAT program, MIPS/MACRA, etc.
Advanced Analytics
Implement multiple Population Health use cases – creating patient
cohorts, identifying high risk patients, physician prescription patterns,
biomarkers for pain severity, etc.
NLP
Leverage cognitive technologies in NLP to read unstructured data residing
in clinical notes, etc. & convert these into usable format
Mobile-based Apps
Build mobile apps for OUD patients – medication adherence, medication
impact & outcomes as well as for physicians – alerts and notifications
during an adverse event, etc.
Opioid-based KPIs
Determine key domains for reporting – prevention, pain management,
oud treatment outcomes, etc. and metrics under each for performance
evaluation